Please login to the form below

TNBC

This page shows the latest TNBC news and features for those working in and with pharma, biotech and healthcare.

Merck CFO: we’re not only about Keytruda

Merck also pointed to the potential for Keytruda growth in new indications like renal cell carcinoma, adjuvant melanoma, small-cell lung cancer (SCLC) and triple-negative breast cancer (TNBC), as well

Latest news

Roche eyes filings for Tecentriq/Avastin combo in liver cancer

Tecentriq is already carving out a niche in indications like triple-negative breast cancer (TNBC) and extensive-stage small cell lung cancer (ES-CLC) where it isn’t facing direct competition
NICE turns down Roche’s Tecentriq for triple-negative breast cancer

negative breast cancer (TNBC), an aggressive form of the disease with few treatment options. ... diagnosed with TNBC in England would be eligible for treatment with the regimen if an access deal can be agreed.
Tecentriq approved in Europe for triple negative breast cancer

TNBC is an aggressive and hard-to-treat subtype of breast cancer, representing around 15% of all breast cancer worldwide, approximately 300, 000 cases every year. ... Roche has a novel therapy in its late stage pipeline for TNBC, ipatasertib (RG7440), a
Triplet approvals for myeloma boost Celgene in Q2

Abraxane is enjoying a sales surge thanks to its use in combination with cancer immunotherapies in indications like non-small cell lung cancer (NSCLC) and triple-negative breast cancer (TNBC), according
Keytruda scores in neoadjuvant triple negative breast cancer combo

Tecentriq still in pole position. Merck &Co. has announced positive early results from its phase 3 trial of Keytruda as a neoadjuvant treatment for patients with triple-negative breast cancer (TNBC). ... in patients with unresectable locally advanced or

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Latest Intelligence

Deal Watch January 2018

The incoming cash will be used by Immunomedics to fund its operations into 2020 including to progress development of sacituzumab govitecan in metastatic triple-negative breast cancer (TNBC), advanced urothelial cancer
Deal Watch February 2017

triple-negative breast cancer (TNBC), small-cell lung cancer (SCLC), non-small-cell lung cancer (NSCLC) and pancreatic cancer. . ... IMMU-132 has FDA Breakthrough Therapy designation for the treatment of patients with TNBC who have failed prior

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

cell carcinoma, Merkel cell carcinoma, and triple-negative breast cancer (TNBC) via chest-wall lesions.8. ... trocar. Further, TAVO has already proven to show robust efficacy in difficult-to-treat patient populations, including metastatic melanoma

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Consultant: competitive salary

Vice President: Competitive Salary Offered

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Account Manager– Medical Communications: (Negotiable - depending on experience)

Senior Medical Writer, MedComms Agency: Salary TBC

Account Director or Senior Account Director: Salary TBC

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Subscribe to our email news alerts

PMHub

Add my company

Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat: A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product: In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team: Enhanced expertise to deliver impactful internal training programmes for healthcare clients...